SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

AMBROSIO, Maria Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.521
AS - Asia 11.187
EU - Europa 7.990
SA - Sud America 1.790
Continente sconosciuto - Info sul continente non disponibili 398
AF - Africa 230
OC - Oceania 19
Totale 45.135
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.775
SG - Singapore 4.291
CN - Cina 2.692
DE - Germania 2.326
IT - Italia 1.854
BR - Brasile 1.404
VN - Vietnam 1.224
HK - Hong Kong 895
UA - Ucraina 863
GB - Regno Unito 600
RU - Federazione Russa 549
TR - Turchia 499
FI - Finlandia 476
BD - Bangladesh 403
FR - Francia 371
CA - Canada 327
JP - Giappone 278
SE - Svezia 260
IN - India 241
PL - Polonia 229
MX - Messico 199
ID - Indonesia 145
AR - Argentina 134
NL - Olanda 123
ZA - Sudafrica 88
IQ - Iraq 85
PK - Pakistan 72
ES - Italia 70
EC - Ecuador 63
CO - Colombia 59
VE - Venezuela 46
LT - Lituania 43
UZ - Uzbekistan 43
MY - Malesia 42
BE - Belgio 41
CR - Costa Rica 39
AT - Austria 38
PH - Filippine 37
JM - Giamaica 31
SA - Arabia Saudita 31
MA - Marocco 28
AE - Emirati Arabi Uniti 26
CL - Cile 24
HN - Honduras 23
IE - Irlanda 22
TT - Trinidad e Tobago 22
SV - El Salvador 21
TN - Tunisia 21
GT - Guatemala 18
KE - Kenya 18
PE - Perù 18
AL - Albania 17
AU - Australia 17
EG - Egitto 16
JO - Giordania 16
PY - Paraguay 15
IL - Israele 14
NP - Nepal 14
BO - Bolivia 13
CH - Svizzera 13
NI - Nicaragua 13
RO - Romania 13
TH - Thailandia 13
AZ - Azerbaigian 12
CW - ???statistics.table.value.countryCode.CW??? 12
DZ - Algeria 12
PR - Porto Rico 12
PS - Palestinian Territory 12
UY - Uruguay 12
GP - Guadalupe 11
CZ - Repubblica Ceca 10
ET - Etiopia 10
LB - Libano 10
GR - Grecia 9
KR - Corea 9
KZ - Kazakistan 9
PT - Portogallo 9
CY - Cipro 8
AM - Armenia 7
IR - Iran 7
LV - Lettonia 7
OM - Oman 7
PA - Panama 7
SY - Repubblica araba siriana 7
DO - Repubblica Dominicana 6
EU - Europa 6
KG - Kirghizistan 6
DK - Danimarca 5
GA - Gabon 5
HU - Ungheria 5
MD - Moldavia 5
MT - Malta 5
NG - Nigeria 5
TW - Taiwan 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
BY - Bielorussia 4
EE - Estonia 4
HR - Croazia 4
Totale 44.678
Salva come PNG Salva come JPEG
Città #
Singapore 2.749
Ashburn 2.721
San Jose 1.707
Woodbridge 1.318
Fairfield 1.156
Chandler 1.111
Council Bluffs 1.082
Santa Clara 964
Jacksonville 907
Hong Kong 881
Beijing 878
Houston 827
Ann Arbor 506
New York 452
Seattle 449
Wilmington 443
Los Angeles 430
Ho Chi Minh City 401
Dallas 366
Cambridge 359
Munich 319
Hanoi 297
Izmir 281
Tokyo 267
Nanjing 265
Milan 250
Princeton 230
Warsaw 219
Addison 216
Lauterbourg 215
Helsinki 196
São Paulo 176
Ferrara 165
San Diego 161
Shanghai 157
Mexico City 133
Rome 125
Phoenix 122
Boardman 118
Toronto 105
Chicago 103
Orem 103
Buffalo 101
Atlanta 98
London 98
Turku 91
Jakarta 89
Brooklyn 82
Denver 81
Washington 79
San Francisco 78
Shenyang 78
Montreal 77
Chennai 74
Hebei 70
Nanchang 70
Hefei 69
Bremen 67
Tianjin 58
Dearborn 56
Bologna 55
Johannesburg 54
Changsha 52
Frankfurt am Main 52
Moscow 52
Haiphong 50
Stockholm 50
Boston 46
Da Nang 46
Mountain View 46
Jiaxing 43
Naples 43
Manchester 41
Rio de Janeiro 40
Falls Church 37
Poplar 37
The Dalles 37
Brussels 36
Tashkent 36
Redwood City 35
North Bergen 34
Jinan 33
Kunming 33
Amsterdam 32
Nuremberg 32
Guangzhou 31
Hải Dương 31
Baghdad 29
Belo Horizonte 29
Philadelphia 28
Ankara 27
Biên Hòa 27
Lahore 27
Quito 26
Mumbai 25
Ningbo 24
San José 24
Brasília 23
Charlotte 23
Norwalk 23
Totale 26.795
Salva come PNG Salva come JPEG
Nome #
Pituitary apoplexy and COVID-19 vaccination: a case report and literature review 1.143
Pituitary and COVID-19 vaccination: a systematic review 530
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 348
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients 325
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 295
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 287
Circadian profile of plasma calcitonin gene-related peptide in healthy man 264
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 264
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 261
Acute lowering of plasma GH concentrations by somatostatin is associated with activation of pituitary-adrenal-axisin healthy young and elderly subjects 257
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 254
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 253
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 252
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 252
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 250
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 241
A defective hypothalamic GHRH activity may contribute to declining GH secretion wuth age in man 240
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 239
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 238
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 238
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 236
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 234
Growth hormone induces chemoresistance in breast cancer cells 234
The mystery of Mont’e Prama: sculptures, acromegaly, and nuragic society 232
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 231
A new VHL polymorphism in a big family from Ferrara 230
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 228
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience 227
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 226
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 226
Growth hormone excess promotes breast cancer chemoresistance 226
Antiproliferative effects of somatostatin analogs in pituitary adenomas 224
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 223
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 223
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 219
Diurnal rhythm of plasma catecholamines in acromegaly 218
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 218
A tool to predict survival in stage IV entero-pancreatic NEN 216
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 216
Aetiology, diagnosis and treatment of thalassemia-associated osteoporosis of the adult 214
Neck paraganglioma and follicular lymphoma: A case report 214
Chromogranin A as a marker of neuroendocrine neoplasia: An Italian Multicenter Study 212
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 210
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 210
Percutaneous Laser Ablation of Liver Metastases from Neuroendocrine Neoplasm. A Retrospective Study for Safety and Effectiveness 210
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 207
Efficacy, safety and adherence to treatment of teriparatide: an observational study 206
Effects of octreotide on gallbladder motor function in acromegaly 206
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 204
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 204
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 203
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major 202
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 200
Glucose metabolism alterations in acromegaly 200
Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS) 200
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 199
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 199
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 199
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 199
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 198
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 198
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 198
Pituitary side effects of old and new drugs. 197
Prevalence of hyopituitarism in post-acute and chronic phase of hemorrhagic stroke 197
Growth hormone and skeletal muscle function 196
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 196
In vitro testing of new somatostatin analogs on pituitary tumor cells 195
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 195
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 194
Efficay and safety of everolimus in metastatic gastroenteropancreatic neuroendocrine tumors 194
ASSE GH-IGF-I NELL'INVECCHIAMENTO 193
Functional hypothalamic and drug-induced amenorrhea: an overview 193
Cerebral aneurysm and acromegaly: a case report 192
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 192
EFFECTS OF SOMATOSTATIN ANALOG TREATMENT ON GLUCOSE METABOLISM IN ACROMEGALY 192
Lumbar spine mineral density Z-score discrepancy by DXA and QCT in thalassaemic major patients 192
Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI) 191
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 190
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 190
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 190
Densitometria Ossea (DEXA): come interpretarla evitando le trappole 189
Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-κB 188
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 187
Tumour-induced osteomalacia: 18 months of 2-weekly burosumab treatment 186
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man 186
Communicating the diagnosis of Klinefelter syndrome to children and adolescents: when, how, and who? 186
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 184
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 183
Delta opioid receptor involvement in endocrine pathophysiology 182
Acromegaly in the elderly patients 182
ASYMPTOMATIC HYPERCALCITONINEMIA IN A PANCREATIC ENDOCRINE CARCINOMA ASSOCIATED WITH A PAPILLARY THYROID CANCER 181
Alcohol use disorders and liver fibrosis: an update 180
Le alterazioni pressorie nell'acromegalia: fattori umorali 180
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 179
Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury 179
Sistema Simpatoadrenomidollare nei pazienti acromegalici 178
Late orbital radiotherapy combined with intravenous methylprednisolone in the management of long-lasting active graves’ orbitopathy: a case report and literature review 177
Real-time PCR is useful to detect menin gene deletions 176
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man 176
Replacement therapy and quality of life improvement in adult GHD patients 176
Totale 22.524
Salva come PNG Salva come JPEG
Categoria #
all - tutte 197.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 14.395
Totale 211.744
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.601 0 0 0 57 89 90 96 90 79 162 187 751
2022/20232.357 234 221 90 310 328 341 127 205 282 26 119 74
2023/20241.350 108 142 73 41 102 263 48 150 45 30 31 317
2024/20255.557 157 149 427 183 640 580 206 198 906 687 782 642
2025/202616.268 1.472 611 1.302 1.891 2.491 1.124 1.955 910 1.486 1.783 770 473
2026/20276.277 1.315 1.619 1.669 1.674 0 0 0 0 0 0 0 0
Totale 45.135